AmerisourceBergen Corporation

ABC
ABC logo

Statistics

gray dotBusiness Model Rating
$87.82Share Price
$19.2 BMarket Cap
8.9%EBIT / EV
4.7%FCF / EV
23.6%ROIC
12.5%Cash ROIC
8.7%3yr Avg Revenue Growth
0.91Current Ratio
star logo

Business Model Diligence

We have a Business Model Diligence rating and review for this stock, but you must have a MagicDiligence Membership to view it. If you are already a member, you need to log in first.

Statistical Diligence

gray wandCurrent member of one or more spells! Log in to see which ones.
check mark The EBIT / Enterprise Value of 8.9% ranks as Very High.
check mark The Free Cash Flow / Enterprise Value of 4.7% ranks as Average.
check mark The Return on Invested Capital Value of 23.6% ranks as Very High.
check mark The Cash Return on Capital Value of 12.5% ranks as Above Average.
check mark The 3 Year Average Revenue Growth Value of 8.7% ranks as Above Average.
check mark Near-term Financial Health appears to be OK. The Current Ratio is 0.91.

Company Description

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution and Other segments. The Pharmaceutical Distribution segment involves in the drug distribution and related services designed to reduce healthcare costs and improve patient outcomes through AmerisourceBergen Drug Corp. and AmerisourceBergen Specialty Group. The Other segment comprises of AmerisourceBergen Consulting Services, World Courier Group, Inc., and MWI Veterinary Supply, Inc. The company was founded on August 28, 2001 and is headquartered in Chesterbrook, PA.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.